Rare diseases
Investigational molecules
Locations
Techno 11 Ro 58, 34036
Gemvax & Kael Co. Ltd. focuses its clinical research on Alzheimer’s disease, with an emphasis on mild to moderate cognitive impairment and cognition in affected participants.
The sponsor’s active trial portfolio includes work across multiple collaborating sites in Asia and other participating countries, reflecting a clinical interest centered on treatment options for Alzheimer’s disease.
Gemvax & Kael Co. Ltd. runs clinical trials in conditions such as Dementia Alzheimer's type, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FinlandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
